raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:75234

Cholesteryl ester storage disease

Synonyms: Cholesterol ester storage disease

Type
Clinical subtype
Group
Subtype of disorder
Inheritance
Autosomal recessive
Age of onset
Adolescent, Adult, Childhood
Status
active

A form of lysosomal acid lipase deficiency characterized by progressive cholesterol esters and triglyceride accumulation in tissues and organs typically presenting with hepatosplenomegaly, liver dysfunction and/or dyslipidemia.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCholesteryl ester storage diseaseCholesterol ester storage disease
frMaladie de stockage des esters du cholestérolMaladie de surcharge en cholestérol estérifié
deCholesterinester-Speicherkrankheit
esEnfermedad por almacenamiento de ésteres de colesterolEnfermedad de acumulación de colesterol éster
itMalattia da accumulo degli esteri del colesterolo
nlCholesterylesterstapelingsziekteCholesterolesterstapelingsziekte
ptDoença de armazenamento de ésteres de colesterol
plChoroba spichrzania estrów cholesteroluChoroba spichrzania estrów cholesterolu
csNemoc ze střádání cholesteryl esteruNemoc ze střádání esteru cholesterolu
ukХвороба накопичення ефірів холестеринуХвороба накопичення ефірів холестерину
zh胆固醇酯贮积病胆固醇酯贮积病
trKolesteril ester depo hastalığıKolesterol ester depo hastalığı

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM278000Evalidated
ICD-10E75.5NTBTattributedvalidated
ICD-115C56.0YNTBTindexvalidated
MONDO0019149Evalidated
MeSHD015217Evalidated
UMLSC0008384Evalidated
GARD12099Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
LIPADisease-causing germline mutation(s) (loss of function) inAssessedHGNC:6617ENSG0000010779861349710q23.31lipase A, lysosomal acid type22227072[PMID]_26225414[PMID]
5

Prevalence and incidence

3 records
TypeClassValueAreaQualificationValidationSource
Prevalence at birth1-9 / 100 0002.5 / 100 000GermanyValue and classValidated17634524[PMID]
Point prevalence1-9 / 1 000 0000.8 / 100 000Specific populationValue and classValidated23424026[PMID]
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

13 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0002240Hepatomegaly
Frequent (79-30%)
HP:0002634Arteriosclerosis
HP:0002014Diarrhea
HP:0001399Hepatic failure
HP:0003124Hypercholesterolemia
HP:0002155Hypertriglyceridemia
HP:0002017Nausea and vomiting
HP:0001744Splenomegaly
Occasional (29-5%)
HP:0010512Adrenal calcification
HP:0001394Cirrhosis
HP:0002040Esophageal varix
HP:0000952Jaundice
HP:0000989Pruritus

Run the differential on the 1 obligate / very frequent terms

Annotation source: 25852113[PMID]

7

Sources for this card